Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Non-steroidal anti-inflammatory drugs: overall risks and management Complementary roles for COX-2 inhibitors and proton pump inhibitors Hawkey CJ; Langman MJGut 2003[Apr]; 52 (4): 600-8Non-steroidal anti-inflammatory drugs (NSAIDs) are well recognised as causing peptic ulceration and ulcer complications. However, several critical issues, including the amount of both gastrointestinal and non-gastrointestinal disease affected by NSAIDs, their interaction with ancillary risk factors, and how to optimise management in subgroups, remain poorly understood. In this article, strategies for subgroups that take account of non-specific gastrointestinal risks, minimisation of residual risk, and the importance of non-gastrointestinal toxicity are suggested, and areas for research identified.|*Proton Pump Inhibitors[MESH]|Anti-Inflammatory Agents, Non-Steroidal/*adverse effects[MESH]|Anti-Ulcer Agents/therapeutic use[MESH]|Cyclooxygenase 2[MESH]|Cyclooxygenase 2 Inhibitors[MESH]|Cyclooxygenase Inhibitors/*adverse effects[MESH]|Drug Interactions[MESH]|Gastrointestinal Diseases/*chemically induced/epidemiology/prevention & control[MESH]|Humans[MESH]|Isoenzymes/metabolism[MESH]|Membrane Proteins[MESH]|Peptic Ulcer/chemically induced[MESH]|Prostaglandin-Endoperoxide Synthases/metabolism[MESH]|Risk Factors[MESH] |
